How are monkeypox cases treated?

[shapanqqccb]

While many monkeypox cases eventually resolve without medications, aside from pain relievers, the Biden administration has allowed doctors to request stockpiled courses of several treatments that have been developed in the past for smallpox.

The most commonly requested of those drugs is the antiviral tecovirimat or TPOXX, which was developed out of federal research launched in 2002 to head off a potential bioterrorism attack. The FDA approved tecovirimat in 2018 to treat smallpox cases. However, that approval was in large part actually based on studies in animals infected with monkeypox and rabbitpox, with the regulator deeming it "not feasible or ethical to conduct efficacy trials in humans" for smallpox.

Doctors looking to get courses of tecovirimat for their monkeypox patients must request them from the CDC under an "expanded access" protocol, which it recently worked with the FDA to streamline.

The agency says that use of the drug is being considered for telegram database people with severe disease, or who have an additional risk factor such as a compromised immune system or lesions in a part of the body that "might constitute a special hazard" like on the genitals.

Can it be contained?
While health officials expect the number of monkeypox cases to continue to climb through at least August, authorities say they still hope to control the current outbreak.

"There is community spread occurring. And while public health officials are working around the clock to contain the outbreak, it's important to say that I think we expect that these numbers will continue to increase," the CDC's Jennifer McQuiston told a webinar hosted by the American Medical Association on.